By targeting the TRiC/CCT complex, we may develop more effective treatments for pertussis and other related infections, highlighting the broader significance of chaperonin complexes in cellular processes and their potential as targets for future antimicrobial strategies. The gene discussed is FLVCR2; the disease is pertussis.